Product Information
The K2 antibody is a highly effective nucleotide molecule that targets alpha-synuclein, a protein associated with neurodegenerative diseases such as Parkinson's and Alzheimer's. This anti-her2 antibody-drug conjugate specifically binds to the HER2 receptor, which is overexpressed in certain types of cancer cells. It works by inhibiting the epidermal growth factor signaling pathway, preventing the growth and proliferation of cancer cells.
This monoclonal antibody has been extensively studied in preclinical and clinical trials, demonstrating its efficacy in treating HER2-positive breast cancer. It has also shown promising results in combination with other targeted therapies, such as trastuzumab, further enhancing its therapeutic potential.
The K2 antibody offers a novel approach to cancer treatment by specifically targeting HER2-positive cells while minimizing damage to healthy tissues. Its unique mechanism of action makes it a valuable tool in the field of life sciences and holds great promise for future therapeutic applications.
Chemical properties
Technical inquiry about: 3D-70-1080S K2 antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.